Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Epic Investment Partners Views: The Week Ahead

Key events this week include China’s Third Plenum (Mon-Thu), the ECB rate decision (Thu) and a host of US bank earnings. 

Later today we have eurozone industrial production and the US Empire manufacturing prints. Markets will be booking for confirmation on the weakening US consumer on Tuesday, when we have the US retail sales print. Eurozone CPI, UK CPI, and US housing starts and industrial production will garner market attention on Wednesday. We also have the King’s Speech to introduce new UK PM Keir Starmer’s legislative agenda. UK unemployment, and US initial jobless claims, Phili. Fed manufacturing index, and Conf. Board LEI readings are due on Thursday.  

Central bank activity includes Fed’s Chair Powell’s interview, and we will hear from Daly on the economy later today. The Fed’s Kugler speaks on Tuesday. The Fed’s Beige Book on Wednesday will give further clues as to the health of the US economy and consumer and we will hear from the central bank’s Barkin on the US economy. Thursday’s main event is the ECB’s rate decision, a hold on rates is expected, and what will be of importance to markets is rhetoric during President Lagarde’s post meeting news conference. On Thursday we will hear from the Fed’s Daly, Logan and Bowman. Then on Friday Williams and Bostic both speak at different events.  

Last week Fed Chair Powell’s Congressional testimonies offered a balanced view of the US economy, acknowledging inflation progress whilst cautioning against premature rate cuts. He noted inflation’s moderation to 2.5% but emphasised the need for sustained progress towards the 2% target. Powell described a strong, but not overheated, labour market and highlighted the Fed’s awareness of risks in both cutting rates too soon or too late. Whilst not signalling specific rate cut plans, his remarks led markets to reprice rate cut odds to two this year. This move was further evidenced by the release of lower-than-expected US CPI data for June which bolstered the disinflation narrative in the US, with headline CPI falling to 3.0%yoy, and the core reading easing to 3.3%yoy. Next, PPI rose slightly more than expected in June, primarily due to increased service costs. The Uni. of Michigan sentiment, expectations and current conditions all dropped, as did the 1-year and 5–10-year inflation expectations, both reading 2.9%. 

Elsewhere, China’s inflation surprised to the downside. In June, CPI rose 0.2%yoy (exp. 0.4%yoy) and PPI slid 0.8%yoy, remaining in deflation. Deflationary pressures continue to impact the economic recovery in China as consumption has been stifled by the real estate slump and weak job market. China’s economic recovery is showing signs of weakness and unevenness. While industrial output climbed and export growth accelerated in June, retail sales growth disappointed. Moreover, this morning we heard that Q2 GDP growth slowed to 4.7%, to the weakest in five quarters. The PBoC is holding off on dramatic measures, instead opting for expanded fiscal spending to stimulate the economy. Despite increased household deposits, consumption remains weak, and money supply growth has hit historic lows. Investors are now focusing on the Third Plenum meeting this week for potential policy support and reforms, though expectations are for modest tweaks rather than major changes. 


Epic Investment Partner’s Key risks & Disclaimers:

EPIC Global Equity Fund (the “Fund”) is a sub-fund of EPIC Funds p.l.c. (the “Company”), which is an open-ended umbrella fund authorised in Ireland as a UCITS fund and regulated by the Central Bank of Ireland. This marketing material has been approved in the UK by EPIC Markets (UK) LLP, trading as EPIC Investment Partners, which is a limited liability partnership incorporated and registered in England and Wales under partnership OC306260 with its registered office at Audrey House, 16-20 Ely Place, London EC1N 6SN. EPIC Markets (UK) LLP is regulated by the Financial Conduct Authority. Distribution of this material and the offer of the Fund are specifically restricted in certain jurisdictions. In particular, but without limitation, neither this material nor shares in the Fund are available to US persons.

This document is for general information purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. It is not a personal recommendation and it should not be regarded as a solicitation or an offer to buy or sell any shares in the Fund. This document represents the views of EPIC Investment Partners at the time of writing. It should not be construed as investment advice. Any person interested in investing in the Fund should conduct their own investigation and analysis of the Fund and should consult their own professional tax, accounting or other advisers as to the risks involved in making such an investment. Full details of the Fund’s investment objectives, investment policy and risks are set out in the Fund’s Prospectus and Supplement which, together with the Key Information Document (“KID”), are available on request and free of charge from Maples Fund Services (Ireland) Limited, 32 Molesworth Street, Dublin 2, Ireland and, in the UK, from EPIC Markets (UK) LLP, Audrey House, 16-20 Ely Place, London EC1N 6SN. Any offering of the Fund is only made on the terms of the current Prospectus, Supplement and KID. A subscription in the Fund can only be made after the provision of the KIID and should be made solely upon the information contained in the Prospectus, Supplement and KID.

An investment in the Fund is not suitable for an investor who cannot sustain a loss on their investment. There is no guarantee of the Fund’s future performance and past performance is not a reliable indicator of future performance. The value of your investment and the income derived from it can go down as well as up, and you may not get back the money you invested. The risks associated with making an investment in the Fund are described in the Prospectus and Supplement but investors should note, in particular, the following: 1) Foreign currency denominated investments are subject to fluctuations in exchange rates that could have a positive or an adverse effect on an investor’s returns. There is also a risk that currency hedging transactions for one share class may in extreme cases adversely affect the net asset value of the other share classes within the same sub-fund since there is no legal segregation between share classes; 2) The Fund is subject to the risk of the insolvency of its counterparties; and 3) Emerging market securities are subject to greater social, political, regulatory, and currency risks than developed market securities. This may impact the liquidity and value of such securities and, consequently, the value of the Fund.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from EPIC Investment Partners. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Investing by yourself or with the help of an advisor depends on your financial goals, level of financial literacy, risk appetite and the time available to you. Explore the pros and cons of both options.
All News

Invest by yourself or use an advisor? The pros and cons

Investing by yourself or with the help of an advisor depends on your financial goals, level of financial literacy, risk appetite and the time available to you. Explore the pros and cons of both options.

All News

Blue Whale Update: Seven Years – Investing Over the Full Market Cycle

In this article, Stephen Yiu reflects on the Blue Whale Growth Strategy’s impressive performance over the past seven years, navigating a full market cycle and global uncertainties. Looking ahead, the strategy remains focused on identifying high-quality businesses poised for growth, with the aim of delivering consistent outperformance for investors in the future.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.